KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Accumulated Expenses: 2010-2024

Historic Other Accumulated Expenses for Exact Sciences (EXAS) over the last 15 years, with Dec 2024 value amounting to $37.8 million.

  • Exact Sciences' Other Accumulated Expenses fell 60.12% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 60.12%. This contributed to the annual value of $37.8 million for FY2024, which is 154.77% up from last year.
  • As of FY2024, Exact Sciences' Other Accumulated Expenses stood at $37.8 million, which was up 154.77% from $14.8 million recorded in FY2023.
  • Exact Sciences' Other Accumulated Expenses' 5-year high stood at $38.3 million during FY2020, with a 5-year trough of $10.2 million in FY2022.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $14.8 million (2023), whereas its average is $20.9 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first spiked by 351.93% in 2020, then tumbled by 66.91% in 2022.
  • Yearly analysis of 5 years shows Exact Sciences' Other Accumulated Expenses stood at $38.3 million in 2020, then decreased by 19.06% to $31.0 million in 2021, then tumbled by 66.91% to $10.2 million in 2022, then soared by 44.63% to $14.8 million in 2023, then surged by 154.77% to $37.8 million in 2024.